Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

β-Endorphin-Induced Feeding: Pharmacological Characterization Using Selective Opioid Antagonists and Antisense Probes in Rats

Robert M. Silva, Maria M. Hadjimarkou, Grace C. Rossi, Gavril W. Pasternak and Richard J. Bodnar
Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 590-596;
Robert M. Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria M. Hadjimarkou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace C. Rossi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavril W. Pasternak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Bodnar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Ventricular administration of the opioid βEND induces feeding in rats. Since its pharmacological characterization has not been fully identified, the present study examined whether equimolar doses of general and selective opioid antagonists as well as AS ODN opioid probes altered spontaneous daytime feeding over a 4-h time course elicited by βEND. βEND-induced feeding was significantly reduced by moderate (20–40-nmol, i.c.v.) doses of general (naltrexone) opioid antagonists, and lower (0.5–40-nmol) doses of selective μ (β-funaltrexamine)-antagonists. Correspondingly, AS ODN probes directed against either exons 1, 3, or 4, but not exon 2, of the μ-opioid receptor clone reduced βEND-induced feeding; a missense ODN control probe was ineffective. The δ-antagonist Nti (20–40 nmol) reduced βEND-induced feeding to a lesser degree, and AS ODN probes targeting exon 1, but not 2 or 3, of the δ-opioid receptor clone significantly reduced βEND-induced feeding. Although the selective κ1-receptor antagonist NBNI (20–40 nmol) significantly reduced βEND-induced feeding, this response was not altered by AS ODN probes directed against either exons 1, 2, or 3 of either the KOR-1 clone or the κ3-like opioid receptor clone. These converging antagonist and AS ODN data firmly implicate the μ-opioid receptor in the mediation of βEND-induced feeding. The relative lack of convergence between the lesser effectiveness of Nti and NBNI in reducing βEND-induced feeding, and the lack of effectiveness of their corresponding AS ODN probes suggest that δ- and κ-receptors play a minimal role in the mediation of this response.

Footnotes

  • Send reprint requests to: Dr. R. J. Bodnar, Department of Psychology, Queens College, City University of New York, 65-30 Kissena Blvd., Flushing, NY 11367. E-mail: richard_bodnar{at}qc.edu

  • This research was supported in part from National Science Foundation Grant IBN98-16699 (to R.J.B.); National Institute on Drug Abuse Grants DA07274 (to G.W.P.), DA00220 (to G.W.P.), and DA00310 (to G.C.R.); and City University of New York Science Fellowships (to R.M.S. and M.M.H.).

  • Abbreviations:
    βEND
    β-endorphin
    AS ODN
    antisense oligodeoxynucleotide
    βFNA
    β-funaltrexamine
    NBNI
    nor-binaltorphamine
    Ntx
    naltrexone
    Nti
    naltrindole
    MOR-1
    μ-opioid receptor clone
    DOR-1
    δ-opioid receptor clone
    KOR-1
    κ-opioid receptor clone
    KOR-3/ORL-1
    κ3-like opioid receptor clone
    MS ODN
    missense oligodeoxynucleotide
    DAMGO
    [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin
    M6G
    morphine-6β-glucuronide
    • Received October 26, 2000.
    • Accepted January 11, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 297 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 297, Issue 2
1 May 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
β-Endorphin-Induced Feeding: Pharmacological Characterization Using Selective Opioid Antagonists and Antisense Probes in Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

β-Endorphin-Induced Feeding: Pharmacological Characterization Using Selective Opioid Antagonists and Antisense Probes in Rats

Robert M. Silva, Maria M. Hadjimarkou, Grace C. Rossi, Gavril W. Pasternak and Richard J. Bodnar
Journal of Pharmacology and Experimental Therapeutics May 1, 2001, 297 (2) 590-596;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

β-Endorphin-Induced Feeding: Pharmacological Characterization Using Selective Opioid Antagonists and Antisense Probes in Rats

Robert M. Silva, Maria M. Hadjimarkou, Grace C. Rossi, Gavril W. Pasternak and Richard J. Bodnar
Journal of Pharmacology and Experimental Therapeutics May 1, 2001, 297 (2) 590-596;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • Rescue Pharmacology on Disease-Related GRIN Variants
  • Obesity thwarts preconditioning in TBI
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics